Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BTTX

Better Therapeutics (BTTX)

Better Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BTTX
DateTimeSourceHeadlineSymbolCompany
15/03/202400:38Business WireBetter Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from NasdaqNASDAQ:BTTXBetter Therapeutics Inc
12/03/202400:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
06/03/202401:25Business WireBetter Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health CentersNASDAQ:BTTXBetter Therapeutics Inc
05/03/202401:25Business WireBetter Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)NASDAQ:BTTXBetter Therapeutics Inc
05/03/202400:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
01/03/202422:08Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BTTXBetter Therapeutics Inc
21/02/202401:25Business WireBetter Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver DiseaseNASDAQ:BTTXBetter Therapeutics Inc
13/02/202408:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
07/02/202401:43Business WireBetter Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes TreatmentNASDAQ:BTTXBetter Therapeutics Inc
07/02/202401:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
26/01/202408:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
24/01/202409:22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BTTXBetter Therapeutics Inc
18/01/202401:28Business WireBetter Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care AloneNASDAQ:BTTXBetter Therapeutics Inc
10/01/202423:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BTTXBetter Therapeutics Inc
09/01/202408:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
05/01/202406:00Business WireBetter Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United StatesNASDAQ:BTTXBetter Therapeutics Inc
02/01/202423:45Business WireBetter Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver DiseaseNASDAQ:BTTXBetter Therapeutics Inc
29/12/202313:23Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BTTXBetter Therapeutics Inc
28/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BTTXBetter Therapeutics Inc
22/12/202309:21Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
21/12/202309:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
21/12/202309:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
21/12/202309:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
14/12/202309:24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BTTXBetter Therapeutics Inc
14/12/202309:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
08/12/202312:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
01/12/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
28/11/202323:45Business WireBetter Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost ReductionsNASDAQ:BTTXBetter Therapeutics Inc
21/11/202309:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
14/11/202323:00Business WireFrost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership AwardNASDAQ:BTTXBetter Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BTTX